Skip to main content
Smart Investors Daily
SW

NASDAQ · SWKHL

SWK Holdings Corporation 9.00% Senior Notes due 2027

Financial Services · Asset Management

$25.06

Up+$0.02 (+0.06%)

Updated Oct 6, 2026, 11:27 PM

SID Score

3.7/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
180.59M
P/E ratio
12.18
Dividend yield
8.99%
52-week range
$24.34 – $25.79
Volume
8.9K
Avg. volume
2.82K

Price performance · SWKHL

SWKHL price history

1M range · 19 trading sessions · Daily adjusted prices

Prices through Oct 5, 2026

SWKHL closed at $25.06 after 19 trading sessions, down 1.69% for the selected period.

Last close
$25.06
Period change
-1.69%
Period low
$25.01
Period high
$25.59
Daily close
View OHLC price history
SWKHL OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 5, 2026$25.07$25.0878$25.04$25.068.9K
Oct 2, 2026$25.08$25.08$25.06$25.067.95K
Sep 30, 2026$25.055$25.07$25.04$25.043.85K
Sep 29, 2026$25.03$25.07$25.03$25.054.35K
Sep 28, 2026$25.04$25.0401$25.00$25.017.67K
Sep 25, 2026$25.0501$25.075$25.01$25.0511.18K
Sep 24, 2026$25.11$25.11$25.05$25.069915.23K
Sep 23, 2026$25.10$25.1201$25.07$25.0920.96K
Sep 22, 2026$25.11$25.12$25.08$25.082.68K
Sep 21, 2026$25.08$25.08$25.05$25.052.4K
Sep 18, 2026$25.06$25.0899$25.001$25.045.41K
Sep 17, 2026$25.09$25.095$25.06$25.06021.68K
Sep 16, 2026$25.13$25.16$25.07$25.092.08K
Sep 15, 2026$25.02$25.14$25.02$25.148.57K
Sep 14, 2026$25.51$25.57$25.51$25.573.66K
Sep 11, 2026$25.54$25.59$25.49$25.58991.98K
Sep 10, 2026$25.54$25.54$25.47$25.5057.26K
Sep 9, 2026$25.50$25.54$25.50$25.53994.08K
Sep 8, 2026$25.49$25.51$25.47$25.496.86K

Latest SWKHL news

The latest Smart Investors Daily articles mentioning SWKHL.

SWKHL research

Overview

Company profile and research snapshot.

Company profile

SWK Holdings Corporation, a specialty finance company that focuses on the healthcare sector. It operates in two segments, Finance Receivables and Pharmaceutical Development. The company provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. It also offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance. In addition, the company engages in the pharmaceutical development, formulation and manufacturing, and licensing business through the Peptelligence platform. Further, it intends to out-license its internal product pipeline to create novel formulations using its proprietary technology to develop treatments for patients and caregivers. The company was formerly known as Kana Software, Inc. and changed its name to SWK Holdings Corporation in December 2009. SWK Holdings Corporation was founded in 1996 and is headquartered in Dallas, Texas.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.